Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis

Autores
Luissi, Aurelia; Pierini, Florencia; Gandino, Ignacio; Botta, Eliana; Brites, Fernando; Boero, Laura; Martin, Maximiliano Emanuel; Meroño, Tomás; Saez, Soledad; Tetzlaff, Walter; Sommerfleck, Fernando; Citera, Gustavo; De Rosa, Javier; Sorroche, Patricia; Soriano, Enrique
Año de publicación
2019
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
Patients with rheumatoid arthritis (RA) have anincreased risk for cardiovascular diseases. Recent studies found that RApatients present dysfunctional high density lipoproteins (HDL) with lowactivity of paraoxonase 1 (PON1), which might contribute to the increasedcardiovascular risk. Tofacitinib has been associated with an increase in totalcholesterol (TC) and low density lipoproteins (LDL-c). The objective of thisstudy was to compare functional markers of HDL at baseline and 3 months aftertofacitinib in patients with RA.
Fil: Luissi, Aurelia. Hospital Italiano; Argentina
Fil: Pierini, Florencia. Hospital Italiano; Argentina
Fil: Gandino, Ignacio. Hospital Italiano; Argentina
Fil: Botta, Eliana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Brites, Fernando. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Boero, Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Martin, Maximiliano Emanuel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Meroño, Tomás. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Saez, Soledad. Hospital Italiano; Argentina
Fil: Tetzlaff, Walter. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Sommerfleck, Fernando. Hospital Italiano; Argentina
Fil: Citera, Gustavo. Hospital Italiano; Argentina
Fil: De Rosa, Javier. Hospital Italiano; Argentina
Fil: Sorroche, Patricia. Hospital Italiano; Argentina
Fil: Soriano, Enrique. Hospital Italiano; Argentina
2019 ACR/ARP Annual Meeting
Estados Unidos
Amercan College of Reumathology
Materia
HDL
RHEUMATOID ARTHRITIS
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/167530
Acceder
id CONICETDig_d23e224c29999504a024ef2664c50900
oai_identifier_str oai:ri.conicet.gov.ar:11336/167530
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritisLuissi, AureliaPierini, FlorenciaGandino, IgnacioBotta, ElianaBrites, FernandoBoero, LauraMartin, Maximiliano EmanuelMeroño, TomásSaez, SoledadTetzlaff, WalterSommerfleck, FernandoCitera, GustavoDe Rosa, JavierSorroche, PatriciaSoriano, EnriqueHDLRHEUMATOID ARTHRITIShttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Patients with rheumatoid arthritis (RA) have anincreased risk for cardiovascular diseases. Recent studies found that RApatients present dysfunctional high density lipoproteins (HDL) with lowactivity of paraoxonase 1 (PON1), which might contribute to the increasedcardiovascular risk. Tofacitinib has been associated with an increase in totalcholesterol (TC) and low density lipoproteins (LDL-c). The objective of thisstudy was to compare functional markers of HDL at baseline and 3 months aftertofacitinib in patients with RA.Fil: Luissi, Aurelia. Hospital Italiano; ArgentinaFil: Pierini, Florencia. Hospital Italiano; ArgentinaFil: Gandino, Ignacio. Hospital Italiano; ArgentinaFil: Botta, Eliana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Brites, Fernando. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Boero, Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Martin, Maximiliano Emanuel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Meroño, Tomás. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Saez, Soledad. Hospital Italiano; ArgentinaFil: Tetzlaff, Walter. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Sommerfleck, Fernando. Hospital Italiano; ArgentinaFil: Citera, Gustavo. Hospital Italiano; ArgentinaFil: De Rosa, Javier. Hospital Italiano; ArgentinaFil: Sorroche, Patricia. Hospital Italiano; ArgentinaFil: Soriano, Enrique. Hospital Italiano; Argentina2019 ACR/ARP Annual MeetingEstados UnidosAmercan College of ReumathologyWiley Blackwell Publishing, Inc2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciatext/plainapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/167530Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis; 2019 ACR/ARP Annual Meeting; Estados Unidos; 2019; 2476-2478CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41108Internacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:20:39Zoai:ri.conicet.gov.ar:11336/167530instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:20:39.386CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
title Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
spellingShingle Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
Luissi, Aurelia
HDL
RHEUMATOID ARTHRITIS
title_short Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
title_full Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
title_fullStr Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
title_full_unstemmed Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
title_sort Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis
dc.creator.none.fl_str_mv Luissi, Aurelia
Pierini, Florencia
Gandino, Ignacio
Botta, Eliana
Brites, Fernando
Boero, Laura
Martin, Maximiliano Emanuel
Meroño, Tomás
Saez, Soledad
Tetzlaff, Walter
Sommerfleck, Fernando
Citera, Gustavo
De Rosa, Javier
Sorroche, Patricia
Soriano, Enrique
author Luissi, Aurelia
author_facet Luissi, Aurelia
Pierini, Florencia
Gandino, Ignacio
Botta, Eliana
Brites, Fernando
Boero, Laura
Martin, Maximiliano Emanuel
Meroño, Tomás
Saez, Soledad
Tetzlaff, Walter
Sommerfleck, Fernando
Citera, Gustavo
De Rosa, Javier
Sorroche, Patricia
Soriano, Enrique
author_role author
author2 Pierini, Florencia
Gandino, Ignacio
Botta, Eliana
Brites, Fernando
Boero, Laura
Martin, Maximiliano Emanuel
Meroño, Tomás
Saez, Soledad
Tetzlaff, Walter
Sommerfleck, Fernando
Citera, Gustavo
De Rosa, Javier
Sorroche, Patricia
Soriano, Enrique
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv HDL
RHEUMATOID ARTHRITIS
topic HDL
RHEUMATOID ARTHRITIS
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Patients with rheumatoid arthritis (RA) have anincreased risk for cardiovascular diseases. Recent studies found that RApatients present dysfunctional high density lipoproteins (HDL) with lowactivity of paraoxonase 1 (PON1), which might contribute to the increasedcardiovascular risk. Tofacitinib has been associated with an increase in totalcholesterol (TC) and low density lipoproteins (LDL-c). The objective of thisstudy was to compare functional markers of HDL at baseline and 3 months aftertofacitinib in patients with RA.
Fil: Luissi, Aurelia. Hospital Italiano; Argentina
Fil: Pierini, Florencia. Hospital Italiano; Argentina
Fil: Gandino, Ignacio. Hospital Italiano; Argentina
Fil: Botta, Eliana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Brites, Fernando. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Boero, Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Martin, Maximiliano Emanuel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Meroño, Tomás. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Saez, Soledad. Hospital Italiano; Argentina
Fil: Tetzlaff, Walter. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Sommerfleck, Fernando. Hospital Italiano; Argentina
Fil: Citera, Gustavo. Hospital Italiano; Argentina
Fil: De Rosa, Javier. Hospital Italiano; Argentina
Fil: Sorroche, Patricia. Hospital Italiano; Argentina
Fil: Soriano, Enrique. Hospital Italiano; Argentina
2019 ACR/ARP Annual Meeting
Estados Unidos
Amercan College of Reumathology
description Patients with rheumatoid arthritis (RA) have anincreased risk for cardiovascular diseases. Recent studies found that RApatients present dysfunctional high density lipoproteins (HDL) with lowactivity of paraoxonase 1 (PON1), which might contribute to the increasedcardiovascular risk. Tofacitinib has been associated with an increase in totalcholesterol (TC) and low density lipoproteins (LDL-c). The objective of thisstudy was to compare functional markers of HDL at baseline and 3 months aftertofacitinib in patients with RA.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Book
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/167530
Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis; 2019 ACR/ARP Annual Meeting; Estados Unidos; 2019; 2476-2478
CONICET Digital
CONICET
url http://hdl.handle.net/11336/167530
identifier_str_mv Effect of Tofacitinib on the qualitative profile of high density lipoproteins molecules in patients with rheumatoid arthritis; 2019 ACR/ARP Annual Meeting; Estados Unidos; 2019; 2476-2478
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41108
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv text/plain
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Internacional
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614189124943872
score 13.070432

Publicaciones similares